3.08BMarket Cap26.29P/E (TTM)
9.600High8.710Low30.76MVolume9.220Open9.320Pre Close280.38MTurnover9.99%Turnover Ratio26.29P/E (Static)344.89MShares15.87052wk High0.98P/B2.75BFloat Cap6.35552wk Low--Dividend TTM307.92MShs Float79.500Historical High--Div YieldTTM9.55%Amplitude0.511Historical Low9.116Avg Price1Lot Size
Riot Platforms Stock Forum
Gapping Up
$EverQuote (EVER.US)$ shares surged 26% after Q4 earnings beat expectations: GAAP EPS reached $0.33 (up by $0.13) and revenue jumped 165% Y/Y to $147.45M. Q1 2025 guidance projects $155–$160M revenue, with robust growth in marketing spend and adjusted EBITDA reinforcing momentum.
$Li Auto (LI.US)$ shares jumped 13% premarket after the company unveiled its first electric SUV, the Li i8. The model quickly be...
MARA is expected to post revenue of USD 187.11M for the four-quarter 2024, which is up 19.35% year-on-year (YOY).
The earnings per share is estimated to be $0.617 down 18% YoY.
Mara Holdings (MARA) Last Positive Earnings Call Saw -44.95% Change Since
MARA last positive earnings call on 12 Nov 2024 gave investors...
Unlike North America-focused miners, $Cango (CANG.US)$ has a global mining footprint across the U.S., Canada, Paraguay, and Ethiopia. Could this decentralized strategy help it adapt bette...
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
No comment yet